Related Articles
Bevacizumab treatment for newly diagnosed glioblastoma: Systematic review and meta-analysis of clinical trials
Efficacy of bevacizumab therapy for unresectable malignant glioma: A retrospective analysis
Valganciclovir and bevacizumab for recurrent glioblastoma: A single-institution experience
Comparison of the outcomes following bevacizumab and/or temozolamide/radiosurgery treatment in patients with glioblastoma
Disease progression patterns of bevacizumab responders with recurrent malignant gliomas